首頁 > 抗體/蛋白 > 藥物對照抗體

瀏覽量: 207

產品名稱： Research Grade Necitumumab ( 奈妥木單抗 )
產品貨號： CSD00193
貨期： 現(xiàn)貨
價格與訂購： 2480
數量：

庫存： 100
規(guī)格： 100μg

產品信息
如何訂購

貨號（Catalog No.）

CSD00193

通用名INN

Necitumumab

純度(Purity

>95%

濃度( Concentration)

1mg/ml

Formulation

PBS buffer PH7.5

Source

CHO cells

內毒素(Endotoxin level)

Please contact with the lab for this information.

產品描述(Description)

Necitumumab is an intravenously administered recombinant monoclonal IgG1 antibody used in the treatment of non-small cell lung cancer (NSCLC) as an EGFR antagonist. It functions by binding to epidermal growth factor receptor (EGFR) and prevents binding of its ligands, a process that is involved in cell proliferation, metastasis, angiogenesis, and malignant progression. Binding of necitumumab to EGFR induces receptor internalization and degradation, thereby preventing further activation of EGFR which is beneficial in NSCLC as many patients have increased protein expression of EGFR. Necitumumab is approved for use in combination with cisplatin and gemcitabine as a first-line treatment for metastatic squamous non-small cell lung cancer (NSCLC).

別名(Alternative names)

11F8,IMC-11F8,LY3012211

靶點;物種(Specificity target name;species)

EGFR/ERBB1 [Homo sapiens]

種類(Species)

Homo sapiens

受體鑒定(Receptor identification)

IgG1-kappa

CAS

906805-06-9

存儲條件(Storage)

Use a manual defrost freezer and avoid repeated freeze-thaw cycles.